11373

    532523

    BIOCON

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BIOCON LIMITED. Share Price Today

    BIOCON LIMITED. is currently trading at ₹436.75, down by ₹0.45 from the previous close. The stock touched an intraday high of ₹442.60 and a low of ₹435.65 during the latest trading session. Over the past one year, BIOCON LIMITED. has delivered a return of 10.12%, while the stock has gained 6.15% in the last one month.

    BIOCON LIMITED. performance

    Today’s low Today’s high
    ₹ 435.65 ₹ 442.60
    ₹ 437.20
    52 week low 52 week high
    ₹ 331.00 ₹ 447.15
    ₹ 437.20
    Open Price ₹ 440.40
    Prev. Close ₹ 437.20
    Volume (Shares) 8811391.00
    Total traded value ₹ 38523.40
    Upper Circuit ₹ 480.90
    Lower Circuit ₹ 393.50
    info

    Investment Returns

    Over 1 Month 6.15% Over 3 Months 22.08% Over 6 Months 16.26% Over 1 Year 10.12%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BIOCON LIMITED. fundamentals


    • Market cap (Cr) 71,250.20
    • P/E Ratio (TTM) 1,900.00
    • Beta 0.73
    • Book Value / share 168.18
    • Return on equity 0.91%
    • EPS (TTM) 1.46
    • Dividend yield 0.11%
    • Net profit/quarter (Cr) 51.00
    info icon alternate text
    • Market cap (Cr) 71,217.60
    • P/E Ratio (TTM) 1,900.00
    • Beta 0.65
    • Book Value / share 168.18
    • Return on equity 0.91%
    • EPS (TTM) 1.46
    • Dividend yield 0.11%
    • Net profit/quarter (Cr) 51.00
    info icon alternate text

    BIOCON LIMITED. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 604.70
    Operating Expense 578.30
    Net Profit 51.00
    Net Profit Margin (%) 8.43
    Earnings Per Share (EPS) 0.32
    EBITDA 110.30
    Effective Tax Rate (%) 11.14
    Particulars DEC 2025 (Values in Cr)
    Revenue 621.30
    Operating Expense 584.30
    Net Profit -76.40
    Net Profit Margin (%) -12.29
    Earnings Per Share (EPS) -0.57
    EBITDA -48.20
    Effective Tax Rate (%) 9.58
    Particulars SEP 2025 (Values in Cr)
    Revenue 583.30
    Operating Expense 631.40
    Net Profit 70.90
    Net Profit Margin (%) 12.15
    Earnings Per Share (EPS) 0.55
    EBITDA 186.70
    Effective Tax Rate (%) 17.26
    Particulars JUN 2025 (Values in Cr)
    Revenue 537.10
    Operating Expense 606.00
    Net Profit -8.30
    Net Profit Margin (%) -1.54
    Earnings Per Share (EPS) -0.07
    EBITDA 81.90
    Effective Tax Rate (%) -9.21
    Particulars MAR 2025 (Values in Cr)
    Revenue 643.80
    Operating Expense 671.50
    Net Profit 21.20
    Net Profit Margin (%) 3.29
    Earnings Per Share (EPS) 0.18
    EBITDA 124.70
    Effective Tax Rate (%) 39.42
    Particulars MAR 2026 (Values in Cr)
    Revenue 2346.40
    Operating Expense 2400.00
    Net Profit 37.20
    Net Profit Margin (%) 1.58
    Earnings Per Share (EPS) 0.27
    EBITDA 330.70
    Effective Tax Rate (%) 27.05
    Particulars MAR 2025 (Values in Cr)
    Revenue 2242.60
    Operating Expense 2431.50
    Net Profit 609.30
    Net Profit Margin (%) 27.16
    Earnings Per Share (EPS) 5.09
    EBITDA 1025.60
    Effective Tax Rate (%) 7.80
    Particulars MAR 2024 (Values in Cr)
    Revenue 2127.30
    Operating Expense 2184.50
    Net Profit 119.30
    Net Profit Margin (%) 5.60
    Earnings Per Share (EPS) 1.00
    EBITDA 470.20
    Effective Tax Rate (%) 20.62
    Particulars MAR 2023 (Values in Cr)
    Revenue 1992.90
    Operating Expense 2155.90
    Net Profit 2848.40
    Net Profit Margin (%) 142.92
    Earnings Per Share (EPS) 23.87
    EBITDA 3157.70
    Effective Tax Rate (%) 4.13
    Particulars MAR 2022 (Values in Cr)
    Revenue 1738.20
    Operating Expense 1785.70
    Net Profit 86.10
    Net Profit Margin (%) 4.95
    Earnings Per Share (EPS) 0.72
    EBITDA 248.30
    Effective Tax Rate (%) 38.36
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 210.60
    ROE % 1.34
    ROCE % 3.76
    Total Debt to Total Equity 0.61
    EBITDA Margin 22.04
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 180.92
    ROE % 6.90
    ROCE % 6.86
    Total Debt to Total Equity 0.84
    EBITDA Margin 29.30
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 164.77
    ROE % 6.89
    ROCE % 6.35
    Total Debt to Total Equity 0.91
    EBITDA Margin 27.57
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 148.81
    ROE % 6.64
    ROCE % 5.68
    Total Debt to Total Equity 0.88
    EBITDA Margin 24.57
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 70.23
    ROE % 10.84
    ROCE % 7.55
    Total Debt to Total Equity 0.60
    EBITDA Margin 24.35
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 166.85
    ROE % 0.91
    ROCE % 1.61
    Total Debt to Total Equity 0.10
    EBITDA Margin 20.57
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 96.63
    ROE % -0.45
    ROCE % 2.07
    Total Debt to Total Equity 0.22
    EBITDA Margin 18.43
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 90.88
    ROE % 0.97
    ROCE % 2.61
    Total Debt to Total Equity 0.15
    EBITDA Margin 21.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 90.91
    ROE % -0.14
    ROCE % 1.50
    Total Debt to Total Equity 0.07
    EBITDA Margin 13.60
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 67.40
    ROE % 1.08
    ROCE % 1.72
    Total Debt to Total Equity 0.00
    EBITDA Margin 14.28
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 3193.60
    Total Assets 63650.60
    Total Liabilities 63650.60
    Total Equity 36621.50
    Share Outstanding 162
    Price to Book Ratio 2.16
    Return on Assets (%) 0.60
    Return on Capital (%) 0.75
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4120.20
    Total Assets 58797.30
    Total Liabilities 58797.30
    Total Equity 27712.50
    Share Outstanding 120
    Price to Book Ratio 3.53
    Return on Assets (%) 1.72
    Return on Capital (%) 2.23
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 2258.70
    Total Assets 56070.70
    Total Liabilities 56070.70
    Total Equity 25274.80
    Share Outstanding 120
    Price to Book Ratio 2.91
    Return on Assets (%) 1.82
    Return on Capital (%) 2.49
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2400.10
    Total Assets 52042.80
    Total Liabilities 52042.80
    Total Equity 22488.80
    Share Outstanding 120
    Price to Book Ratio 2.27
    Return on Assets (%) 0.88
    Return on Capital (%) 1.15
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1747.50
    Total Assets 20394.00
    Total Liabilities 20394.00
    Total Equity 9470.00
    Share Outstanding 120
    Price to Book Ratio 4.96
    Return on Assets (%) 3.17
    Return on Capital (%) 4.51
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 91.70
    Total Assets 29270.60
    Total Liabilities 29270.60
    Total Equity 27079.80
    Share Outstanding 162
    Price to Book Ratio 2.16
    Return on Assets (%) 0.12
    Return on Capital (%) 0.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 249.80
    Total Assets 15621.10
    Total Liabilities 15621.10
    Total Equity 11524.40
    Share Outstanding 120
    Price to Book Ratio 3.53
    Return on Assets (%) 3.90
    Return on Capital (%) 4.23
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 585.70
    Total Assets 13768.20
    Total Liabilities 13768.20
    Total Equity 10912.30
    Share Outstanding 120
    Price to Book Ratio 2.91
    Return on Assets (%) 0.86
    Return on Capital (%) 0.92
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 720.30
    Total Assets 13029.90
    Total Liabilities 13029.90
    Total Equity 10916.00
    Share Outstanding 120
    Price to Book Ratio 2.27
    Return on Assets (%) 21.86
    Return on Capital (%) 23.32
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 689.30
    Total Assets 8869.00
    Total Liabilities 8869.00
    Total Equity 8092.90
    Share Outstanding 120
    Price to Book Ratio 4.96
    Return on Assets (%) 0.97
    Return on Capital (%) 1.05
    Particulars MAR 2026 (Values in Cr)
    Net Income 368.80
    Cash from Operations 2236.60
    Cash from Investing -2082.10
    Cash from Financing -923.60
    Net change in Cash -1011.70
    Free Cash Flow 4034.50
    Particulars MAR 2025 (Values in Cr)
    Net Income 1429.40
    Cash from Operations 4520.80
    Cash from Investing -234.10
    Cash from Financing -1854.00
    Net change in Cash 1973.10
    Free Cash Flow 6657.40
    Particulars MAR 2024 (Values in Cr)
    Net Income 1297.80
    Cash from Operations 3246.20
    Cash from Investing -1004.50
    Cash from Financing -2332.70
    Net change in Cash -383.30
    Free Cash Flow 4926.70
    Particulars MAR 2023 (Values in Cr)
    Net Income 643.00
    Cash from Operations 2081.10
    Cash from Investing -14281.80
    Cash from Financing 13048.70
    Net change in Cash 619.40
    Free Cash Flow 3677.10
    Particulars MAR 2022 (Values in Cr)
    Net Income 771.60
    Cash from Operations 1438.60
    Cash from Investing -1699.10
    Cash from Financing 242.10
    Net change in Cash -280.40
    Free Cash Flow 3136.39
    Particulars MAR 2026 (Values in Cr)
    Net Income 37.20
    Cash from Operations -158.70
    Cash from Investing -6581.70
    Cash from Financing 6602.00
    Net change in Cash -159.80
    Free Cash Flow 124.30
    Particulars MAR 2025 (Values in Cr)
    Net Income 609.30
    Cash from Operations 666.50
    Cash from Investing -991.80
    Cash from Financing 494.80
    Net change in Cash 126.90
    Free Cash Flow 983.90
    Particulars MAR 2024 (Values in Cr)
    Net Income 119.30
    Cash from Operations -95.70
    Cash from Investing -296.40
    Cash from Financing 343.60
    Net change in Cash -76.00
    Free Cash Flow 204.70
    Particulars MAR 2023 (Values in Cr)
    Net Income 2848.40
    Cash from Operations 260.40
    Cash from Investing -1177.80
    Cash from Financing 1039.40
    Net change in Cash 80.90
    Free Cash Flow 522.30
    Particulars MAR 2022 (Values in Cr)
    Net Income 86.10
    Cash from Operations 76.00
    Cash from Investing -305.60
    Cash from Financing 112.00
    Net change in Cash -146.00
    Free Cash Flow 315.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD. 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 431.50 19.03 3.12 1269.95 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD 482.50 52.16 4.42 5117.21 118.35 552.90

    BIOCON LIMITED. shareholding pattern

    Holding
    25.23%
    44.67%
    8.16%
    21.92%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    BIOCON LIMITED. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    437.20 -0.79 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 432.40
    • 26 Days 420.10
    • 10 Days 426.50
    • 50 Days 412.70
    • 12 Days 425.20
    • 100 Days 401.40
    • 20 Days 421.90
    • 200 Days 389.30
    438.15 PIVOT
    First Support 431.85 First Resistance 443.50 Second Support 426.50 Second Resistance 449.80 Third Support 420.20 Third Resistance 455.15
    RSI 60.18 ADX 24.30 MACD 5.04 Williams % R -19.02 Commodity Channel Index (CCI) 141.48
    Date 2026-07-17 Week 4506156.00 Same Day 5291062.00 Month 2711217.00
    1 Year 0.73 3 Year 0.99
    Over 1 Month
    6.15% down
    Over 1 Year
    10.12% down
    Over 3 Months
    22.08% down
    Over 3 Years
    18.22% down
    Over 6 Months
    16.26% down
    Over 5 Years
    1.22% down

    BIOCON LIMITED. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    03 Jul 2026 0.5 Final 03 Jul 2026 Equity shares
    04 Jul 2025 0.5 Final 04 Jul 2025 Equity shares
    05 Jul 2024 0.5 Final 05 Jul 2024 Equity shares
    07 Jul 2023 1.5 Final 07 Jul 2023 Equity shares
    30 Jun 2022 0.5 Final 01 Jul 2022 Equity shares
    18 Jul 2019 0.5 Final 19 Jul 2019 Equity shares
    19 Jul 2018 1.0 Final 20 Jul 2018 Equity shares
    20 Jul 2017 1.0 Final 22 Jul 2017 Equity shares
    17 Mar 2016 5.0 Interim 19 Mar 2016 Equity shares
    09 Apr 2015 5.0 Interim 10 Apr 2015 Equity shares
    10 Jul 2014 5.0 Final 12 Jul 2014 Equity shares
    11 Jul 2013 2.5 Special 13 Jul 2013 Equity shares
    11 Jul 2013 5.0 Final 13 Jul 2013 Equity shares
    05 Jul 2012 5.0 Final 07 Jul 2012 Equity shares
    07 Jul 2011 3.0 Final 09 Jul 2011 Equity shares
    05 May 2011 1.5 Interim 06 May 2011 Equity shares
    08 Jul 2010 3.5 Final 10 Jul 2010 Equity shares
    13 Jul 2009 3.0 Final 10 Jul 2009 Equity shares
    03 Jul 2008 2.0 Special 05 Jul 2008 Equity shares
    03 Jul 2008 3.0 Final 05 Jul 2008 Equity shares
    28 Jun 2007 3.0 Final 02 Jul 2007 Equity shares
    29 Jun 2005 0.0 Final 10 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    13 Jun 2019 12 Jun 2019 1:1
    17 Jun 2017 15 Jun 2017 2:1
    12 Sep 2008 11 Sep 2008 1:1
    Dividend date Dividend amount Dividend type Record date Instrument type
    03 Jul 2026 0.5 Final 03 Jul 2026 Equity shares
    04 Jul 2025 0.5 Final 04 Jul 2025 Equity shares
    05 Jul 2024 0.5 Final 05 Jul 2024 Equity shares
    07 Jul 2023 1.5 Final 07 Jul 2023 Equity shares
    30 Jun 2022 0.5 Final 01 Jul 2022 Equity shares
    18 Jul 2019 0.5 Final 19 Jul 2019 Equity shares
    19 Jul 2018 1.0 Final 20 Jul 2018 Equity shares
    20 Jul 2017 1.0 Final 22 Jul 2017 Equity shares
    17 Mar 2016 5.0 Interim 19 Mar 2016 Equity shares
    09 Apr 2015 5.0 Interim 10 Apr 2015 Equity shares
    10 Jul 2014 5.0 Final 12 Jul 2014 Equity shares
    11 Jul 2013 2.5 Special 13 Jul 2013 Equity shares
    11 Jul 2013 5.0 Final 13 Jul 2013 Equity shares
    05 Jul 2012 5.0 Final 07 Jul 2012 Equity shares
    07 Jul 2011 3.0 Final 09 Jul 2011 Equity shares
    05 May 2011 1.5 Interim 06 May 2011 Equity shares
    08 Jul 2010 3.5 Final 10 Jul 2010 Equity shares
    13 Jul 2009 3.0 Final 10 Jul 2009 Equity shares
    03 Jul 2008 2.0 Special 05 Jul 2008 Equity shares
    03 Jul 2008 3.0 Final 05 Jul 2008 Equity shares
    28 Jun 2007 3.0 Final 02 Jul 2007 Equity shares
    29 Jun 2005 0.0 Final 10 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    13 Jun 2019 12 Jun 2019 1:1
    17 Jun 2017 15 Jun 2017 2:1
    12 Sep 2008 11 Sep 2008 1:1

    Top Gainers

    Top Losers

    Biocon Share Result Highlights

    Metric

    Value

    Share Price

    ₹325.45 (as of 07 Nov 2024)

    Daily Change

    +2.60 (0.80%) (as of 07 Nov 2024)

    Day Range

    Low: ₹322.15, High: ₹328.35 (07 Nov 2024)

    52-Week Range

    Low: ₹222.55, High: ₹395.80 (2024)

    Market Capitalization

    ₹39,073.53 Cr (as of 07 Nov 2024)

    PE Ratio (TTM)

    922.14 (as of 07 Nov 2024)

    Earnings Per Share (EPS)

    ₹0.35 (TTM as of 07 Nov 2024)

    Dividend Yield

    0.15% (as of 07 Nov 2024)

    Total Traded Volume

    11,44,939 shares (as of 07 Nov 2024)

    Upper Circuit Limit

    ₹355.10 (as of 07 Nov 2024)

    Lower Circuit Limit

    ₹290.60 (as of 07 Nov 2024)

    Key Highlights

    • In 2024, Biocon share price reached a 52-week low of ₹222.55 and a high of ₹395.80.

    • Biocon’s market cap is valued at ₹39,073.53 Cr as of 07 Nov 2024.

    • A PE ratio of 922.14 reflects Biocon’s high valuation relative to earnings, as of TTM ending 07 Nov 2024.

    Biocon Share Annual Reports

    Metric

    Value

    Revenue

    ₹525.40 Cr (for quarter ending Sep 2024)

    Operating Expense

    ₹578.00 Cr (for quarter ending Sep 2024)

    Net Profit

    ₹3.20 Cr (for quarter ending Sep 2024)

    Net Profit Margin

    0.60% (for quarter ending Sep 2024)

    Earnings Per Share (EPS)

    ₹0.03 (for quarter ending Sep 2024)

    EBITDA

    ₹111.10 Cr (for quarter ending Sep 2024)

    Effective Tax Rate

    84.68% (for quarter ending Sep 2024)

    Dividend Yield

    0.15% (as of 07 Nov 2024)

    52-Week Range

    Low: ₹222.55, High: ₹395.80 (for 2024)

    Key Highlights

    • Revenue for Biocon reached ₹525.40 Cr for the quarter ending Sep 2024.

    • Despite operating expenses of ₹578.00 Cr, Biocon maintained a net profit of ₹3.20 Cr.

    • EPS was relatively low at ₹0.03, reflecting earnings for the quarter ending Sep 2024.

    • Dividend yield stands at 0.15% as of 07 Nov 2024, offering shareholders a modest return.

    Biocon Share Dividend

    Dividend Details

    Value

    Latest Dividend Amount

    ₹1.5 per share (07 Jul 2023)

    Dividend Type

    Final Dividend (07 Jul 2023)

    Previous Dividend

    ₹0.5 per share (30 Jun 2022)

    Dividend Frequency

    Annual

    Dividend Yield

    0.15% (as of 07 Nov 2024)

    Historical Dividend Amounts

    ₹1 per share (20 Jul 2018), ₹5 per share (17 Mar 2016)

    Key Highlights

    • The most recent Biocon share dividend was ₹1.5 per share, declared on 07 Jul 2023.

    • Biocon has maintained an annual dividend frequency, with varying amounts over the years.

    • In 2024, dividend yield stands at 0.15%, reflecting a steady return for shareholders.

    • Historical dividends include ₹1 per share in 2018 and a high of ₹5 per share in 2016.

    Popular FAQs

    1. Who is the CEO of Biocon Ltd?

    Siddharth Mittal has served as CEO of Biocon Ltd since 1 December 2019. He leads Biocon’s strategic direction, focusing on the company’s growth in biopharmaceuticals and driving its innovations in the global market.

     

    2. When was Biocon Ltd established?

    Biocon Ltd was established in 1978. It began as a joint venture with Biocon Biochemicals Ltd, Ireland, and has since evolved into a leading biotechnology company, making significant contributions in biopharmaceuticals.

     

    3. What factors influence the Biocon Share Price?

    The Biocon Share Price is influenced by various factors, including quarterly earnings, regulatory changes, market trends, and developments within the biotechnology sector. Economic conditions and investor sentiment also play a role.

     

    4. Is Biocon Ltd debt-free?

    No, Biocon Ltd is currently not debt-free. The company strategically uses debt to finance its operations, support expansion plans, and invest in research and development within the biopharmaceutical industry.

     

    5. What is the CAGR of Biocon Share?

    The Compound Annual Growth Rate (CAGR) of Biocon Share over different time frames is 16% over 10 years, 4% over 5 years, -3% over 3 years, and 42% over 1 year.

     

    6. How has the Biocon Share Price performed over the past year?

    Over the past year, the Biocon Share Price has risen by 42%, reflecting strong market performance, positive financial results, and heightened investor confidence in Biocon’s strategic direction and growth.

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Biocon Ltd?

    Answer Field

    Biocon Ltd share price is for NSE ₹ 436.75 & for BSE ₹ 436.75 as on Jul 20 2026 10:10 AM.

    What is the Market Cap of Biocon Ltd Share?

    Answer Field

    The market cap of Biocon Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 20 2026 10:10 AM.

    What is the 52 Week High and Low of Biocon Ltd?

    Answer Field

    The 52 Week High and Low of Biocon Ltd for NSE is ₹ 447.15 and ₹ 331.00 and for BSE is ₹ 447.00 and ₹ 331.00.

    What is 1 year return for Biocon Ltd?

    Answer Field

    The 1 year returns on the stock has been 10.12%.

    What is the P/E Ratio of Biocon Ltd Share?

    Answer Field

    As on Jul 20 2026 10:10 AM the price-to-earnings (PE) ratio for Biocon Ltd share is 1900.00.

    What is the PB ratio of Biocon Ltd Share?

    Answer Field

    As on Jul 20 2026 10:10 AM, the price-to-book (PB) ratio for Biocon Ltd share is 168.18.

    How to Buy Biocon Ltd Share?

    Answer Field

    You can trade in Biocon Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Biocon Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Biocon Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Biocon Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    Who is the CEO of Biocon Ltd?

    Answer Field

    Siddharth Mittal has served as CEO of Biocon Ltd since 1 December 2019. He leads Biocon’s strategic direction, focusing on the company’s growth in biopharmaceuticals and driving its innovations in the global market.

    When was Biocon Ltd established?

    Answer Field

    Biocon Ltd was established in 1978. It began as a joint venture with Biocon Biochemicals Ltd, Ireland, and has since evolved into a leading biotechnology company, making significant contributions in biopharmaceuticals.

    What factors influence the Biocon Share Price?

    Answer Field

    The Biocon Share Price is influenced by various factors, including quarterly earnings, regulatory changes, market trends, and developments within the biotechnology sector. Economic conditions and investor sentiment also play a role.

    Is Biocon Ltd debt-free?

    Answer Field

    No, Biocon Ltd is currently not debt-free. The company strategically uses debt to finance its operations, support expansion plans, and invest in research and development within the biopharmaceutical industry.

    What is the CAGR of Biocon Share?

    Answer Field

    The Compound Annual Growth Rate (CAGR) of Biocon Share over different time frames is 16% over 10 years, 4% over 5 years, -3% over 3 years, and 42% over 1 year.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |